Takeaway
Neuromuscular junction (NMJ) abnormalities are common in people with mitochondrial disease and is independent of coexisting neuropathy and myopathy.
Why this matters
These findings suggest specific involvement of the NMJ in people with mitochondrial disease.
Modulators of neuromuscular transmission may offer therapeutic benefit in some people with mitochondrial disease.